A carregar...
Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
Brentuximab vedotin is a monoclonal antibody that targets the CD30 antigen. It is indicated for the treatment of Hodgkin lymphoma. Hypersensitivity reactions have occurred during infusions of brentuximab vedotin, ranging from mild to severe. We report a case of a 46-year-old male with stage IV nodul...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6141060/ https://ncbi.nlm.nih.gov/pubmed/30237942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2981 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|